2-Aminoethyl Methyl Sulfone Hydrochloridis CAS 104458-24-4 Puritas >99.0% (HPLC)

Description:

2-Aminoethyl Methyl Sulfone Hydrochloridis

CAS: 104458-24-4

Puritas: >99.0% (HPLC)

Aspectus: Alba vel Off-White pulveris

Ditosylate Monohydratorum

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Lapatinib intermedia:

Lapatinib Base	CAS 231277-92-2
Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloridis	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Acidi Furanboronic	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Chemical Properties:

Nomen chemicum	2-Aminoethyl Methyl Sulfone Hydrochloridis
Synonyma	2-Aminoethylmetylsulfone Hydrochloride;2-(Methylsulfonyl)ethanamine Hydrochloridi;2-(Methylsulfonyl)Ethylamine HCl;2-Aminoethylmetyl Sulfone HCl;Lapatinib medium 1
CAS Number	104458-24-4
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C3H9NO2S·HCl
M. Pondus	159.63
Liquescens punctum	165.0 ad 172.0℃
Stabilitas	Hygroscopic
Solubilitas	Solutum in Methanol
Sample	Praesto
Origin	Shanghai, China
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba vel Off-White pulveris
Puritas / Analysis Methodus	>99.0% (HPLC)
Liquescens punctum	165.0~172.0℃
Damnum in Siccatio	<1.00%
Residere in Ignition	<0.50%
Totalis immunditias	<1.00%
Metalla gravia (ut Pb)	<20ppm
Test Standard	Enterprise Standard
Consuetudinem	Medium API (CAS 388082-77-7)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

104458-24-4 - Applicatio:

2-Aminoethyl Methyl Sulfone Hydrochloridis (CAS: 104458-24-4) media est API (CAS: 388082-77-7).(CAS: 388082-77-7) Novum pharmacum iaculis pro curatione cancri pectoris a GlaxoSmithKline evoluta, quod probatum est in mercatu ab administratione US Cibus et medicamentis die XIII mensis Martii, anno MMVII. Nunc probata indicia mastocarcinoma tractata sunt. cum (CAS: 388082-77-7) et Cancri capecitabino vel metastatico pectoris, et in aliis medicamentis primigenii curandae sunt aegros carcinomati.Nomen artis eius est Tykerb in Civitatibus Foederatis Americae.Die 14 Decembris 2007, Medicinae Europaeae Agency (EMEA) mercaturae in Europa probatae sunt, et nomen mercatum Tyverb est.Pectus cancer iaculis therapiae hypotheticae est curatio pro oncogene cum occursu et progressu carcinomatis, et pro expressio affinis ejus producti.Medicamenta hypothetica iaculis moderantur mutationes locutionum generum in cellula per claudentes signo translationi cellae tumoris vel cellulae affinis, inhibendo vel occidendo cellulas tumores.